Table 1.
Serial |
Compound |
R |
Binding |
Inhibitory |
---|---|---|---|---|
number |
code |
|
free energy |
constant (nM) |
(Kcal/mole) | ||||
1 |
Efavirenz |
- |
−12.02 |
1.56 |
|
(standard) |
|
|
|
2 |
TNK-651 |
- |
−11.88 |
1.95 |
3 |
4a |
H |
−8.13 |
1,100.0 |
4 |
4b |
4-OCH3 |
−7.65 |
2,460.0 |
5 |
4c |
4-CH3 |
−8.5 |
588.3 |
6 |
4d |
4-Cl |
−7.79 |
1,930.0 |
7 |
4e |
3-OCH3 |
−8.62 |
479.1 |
8 |
4f |
3-CH3 |
−8.61 |
484.7 |
9 |
4g |
3-Cl |
−8.87 |
315.7 |
10 |
4h |
2-OCH3 |
−7.94 |
1,510.0 |
11 |
4i |
2-CH3 |
−8.2 |
975.83 |
12 |
4j |
2-Cl |
−8.2 |
975.83 |
13 |
4k |
4-NO2 |
−10.53 |
19.11 |
14 |
4l |
3-NO2 |
−10.89 |
10.38 |
15 |
4m |
2-NO2 |
10.46 |
22.86 |
16 |
4n |
2,4-diCH3 |
−8.87 |
313.63 |
17 |
4o |
3,4-diCH3 |
10.49 |
20.37 |
18 | 4p | 2-Cl, 3-CH3 | −10.71 | 14.2 |
4k, 4l, 4m, 4o, and 4p showed satisfactory and comparable docking results as that of standard drug efavirenz and TNK-651 (the same thing has been discussed under the subsection “In vitro HIV-1 RT inhibitory activity” of the “Results and discussion” section).